Trexquant Investment’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01M | Buy |
|
|||||
|
2025
Q1 | $2.92M | Sell |
|
|||||
|
2024
Q4 | $3.72M | Sell |
|
|||||
|
2024
Q3 | $6.7M | Sell |
|
|||||
|
2024
Q2 | $6.41M | Buy |
|
|||||
|
2024
Q1 | $594K | Sell |
|
|||||
|
2023
Q4 | $2.52M | Sell |
|
|||||
|
2023
Q3 | $4.2M | Buy |
|
|||||
|
2023
Q2 | $2.36M | Buy |
|
|||||
|
2023
Q1 | $971K | Sell |
|
|||||
|
2022
Q4 | $2.48M | Buy |
|
|||||
|
2022
Q3 | $1.34M | Buy |
|
|||||
|
2022
Q2 | $778K | Buy |
|
|||||
|
2022
Q1 | $978K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $182K | Sell |
|
|||||
|
2021
Q2 | $318K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $214K | Sell |
|
|||||
|
2017
Q1 | $427K | Buy |
|
|||||
|
2016
Q4 | $231K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $630K | Sell |
|
|||||
|
2015
Q2 | $1.89M | Buy |
|
|||||
|
2015
Q1 | $204K | Buy |
|